FR2385722A1 - Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique - Google Patents
Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutiqueInfo
- Publication number
- FR2385722A1 FR2385722A1 FR7809661A FR7809661A FR2385722A1 FR 2385722 A1 FR2385722 A1 FR 2385722A1 FR 7809661 A FR7809661 A FR 7809661A FR 7809661 A FR7809661 A FR 7809661A FR 2385722 A1 FR2385722 A1 FR 2385722A1
- Authority
- FR
- France
- Prior art keywords
- preparation process
- therapeutic application
- cephalosporin derivatives
- new cephalosporin
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/50—Nitrogen atoms bound to hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Abstract
L'invention concerne des dérivés de céphèmes, répondant à la formule générale I :
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19772714880 DE2714880A1 (de) | 1977-04-02 | 1977-04-02 | Cephemderivate und verfahren zu ihrer herstellung |
DE19772716707 DE2716707A1 (de) | 1977-04-02 | 1977-04-15 | Cephemderivate und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2385722A1 true FR2385722A1 (fr) | 1978-10-27 |
FR2385722B1 FR2385722B1 (fr) | 1985-09-27 |
Family
ID=25771827
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7809661A Expired FR2385722B1 (fr) | 1977-04-02 | 1978-03-31 | Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique |
FR8110233A Granted FR2485017A1 (fr) | 1977-04-02 | 1981-05-22 | Nouveaux derives de cephalosporine et leur application en therapeutique |
FR8110234A Granted FR2485018A1 (fr) | 1977-04-02 | 1981-05-22 | Nouveaux derives de cephalosporine et leur application en therapeutique |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8110233A Granted FR2485017A1 (fr) | 1977-04-02 | 1981-05-22 | Nouveaux derives de cephalosporine et leur application en therapeutique |
FR8110234A Granted FR2485018A1 (fr) | 1977-04-02 | 1981-05-22 | Nouveaux derives de cephalosporine et leur application en therapeutique |
Country Status (28)
Country | Link |
---|---|
US (4) | US4758556A (fr) |
JP (2) | JPS5858354B2 (fr) |
AT (1) | AT367425B (fr) |
AU (1) | AU528277B2 (fr) |
BE (1) | BE865632A (fr) |
CA (1) | CA1259606A (fr) |
CH (1) | CH638810A5 (fr) |
CS (1) | CS208747B2 (fr) |
DD (1) | DD137231A5 (fr) |
DE (2) | DE2714880A1 (fr) |
DK (1) | DK165060C (fr) |
ES (2) | ES468475A1 (fr) |
FI (1) | FI70221C (fr) |
FR (3) | FR2385722B1 (fr) |
GB (1) | GB1604971A (fr) |
GR (1) | GR73632B (fr) |
HK (1) | HK39083A (fr) |
IE (1) | IE47211B1 (fr) |
IL (1) | IL54407A (fr) |
IT (1) | IT1093750B (fr) |
LU (1) | LU79350A1 (fr) |
NL (1) | NL7803486A (fr) |
NO (1) | NO160211C (fr) |
NZ (1) | NZ186842A (fr) |
OA (1) | OA05928A (fr) |
PT (1) | PT67856B (fr) |
SE (2) | SE448378B (fr) |
YU (1) | YU41827B (fr) |
Cited By (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2399418A1 (fr) * | 1977-03-14 | 1979-03-02 | Fujisawa Pharmaceutical Co | Procede de preparation d'acides iminoacetiques et nouveaux produits ainsi obtenus, utilises pour la synthese d'acides cepham- ou cephem-carboxyliques |
FR2453161A1 (fr) * | 1978-08-31 | 1980-10-31 | Fujisawa Pharmaceutical Co | Procede de preparation de derives d'acide thiazolylacetique et nouveaux produits ainsi obtenus |
FR2476647A2 (fr) * | 1980-02-26 | 1981-08-28 | Roussel Uclaf | Procede de preparation de derives de l'acide 2-(2-amino protege 4-thiazolyl) 2-alkoxyimino acetique isomere syn |
FR2488258A1 (fr) * | 1980-08-11 | 1982-02-12 | American Cyanamid Co | Acide 7-beta-(alpha-syn-methoxyimino-alpha - (2-aminothiazol-4-yl) - acetamino)-3-((1,2,3-thiadiazol-5-ylthio) methyl)-3-cepheme-4-carboxylique et derives alkyliques en c1-c6 de celui-ci, compositions contenant ces composes et leurs applications |
EP0045937A2 (fr) * | 1980-08-11 | 1982-02-17 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de céphalosporine et procédés pour leur préparation |
EP0049119A2 (fr) * | 1980-09-30 | 1982-04-07 | Sankyo Company Limited | Dérivés de céphalosporines, leur préparation et compositions pharmaceutiques les contenant |
EP0049499A2 (fr) * | 1980-10-06 | 1982-04-14 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Dérivés de céphalosporine, leur préparation, compositions pharmaceutiques les contenant et intermédiaires pour leur préparation |
FR2494279A1 (fr) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | Nouvelles oxacephalosporines, leur preparation et les medicaments qui les contiennent |
EP0064256A2 (fr) * | 1981-05-02 | 1982-11-10 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
FR2505338A1 (fr) * | 1981-05-11 | 1982-11-12 | Rhone Poulenc Sante | Nouvelles oxacephalosporines et leur preparation |
FR2505339A1 (fr) * | 1981-05-11 | 1982-11-12 | Rhone Poulenc Sante | Nouvelles oxacephalosporines et leur preparation |
EP0064740A2 (fr) * | 1981-05-12 | 1982-11-17 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
FR2505840A1 (fr) * | 1981-05-13 | 1982-11-19 | Roussel Uclaf | Nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique, leur procede de preparation et leur application comme medicaments |
FR2508458A1 (fr) * | 1981-06-29 | 1982-12-31 | Sandoz Sa | Nouveaux derives de l'acide cephalosporanique, leur preparation et leur application comme medicaments |
FR2512448A1 (fr) * | 1981-09-08 | 1983-03-11 | Lilly Co Eli | Isoquinoleinium-betaines de cephalosporine et son application pharmaceutique |
FR2512449A1 (fr) * | 1981-09-08 | 1983-03-11 | Lilly Co Eli | Quinoleinium-betaines de cephalosporine et leur application pharmacolique |
EP0074268A2 (fr) * | 1981-09-08 | 1983-03-16 | Eli Lilly And Company | Dérivés de céphalosporines thiéno- et furopyridinium substitués |
EP0074645A2 (fr) * | 1981-09-14 | 1983-03-23 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de céphalosporine, procédés pour leur préparation et compositions pharmaceutiques les contenant |
EP0075600A1 (fr) * | 1981-03-16 | 1983-04-06 | MITSUI TOATSU CHEMICALS, Inc. | Derives de 2-thiazolamines, leur procede de preparation et composition medicinale les contenant |
FR2514004A1 (fr) * | 1981-10-02 | 1983-04-08 | Lilly Co Eli | Antibiotiques de dioximino-cephalosporines |
EP0076528A2 (fr) * | 1980-02-18 | 1983-04-13 | Roussel-Uclaf | Nouvelles oximes dérivées de l'acide 3-alkyloxy ou 3-alkylthiométhyl 7-amino thiazolylacétamido céphalosporanique et leur préparation |
EP0078532A2 (fr) * | 1981-11-03 | 1983-05-11 | Hoechst Aktiengesellschaft | Sels cristallins de céfodizim et procédé pour leur préparation |
EP0081971A2 (fr) * | 1981-12-08 | 1983-06-22 | Tanabe Seiyaku Co., Ltd. | Dérivé de céphalosporine et procédé pour sa préparation |
EP0095329A2 (fr) * | 1982-05-20 | 1983-11-30 | Glaxo Group Limited | Céphalosporines antibiotiques |
FR2529555A1 (fr) * | 1982-06-30 | 1984-01-06 | Glaxo Group Ltd | Cephalosporines a activite antibiotique, leur procede de preparation et leur application en therapeutique |
FR2529556A1 (fr) * | 1982-06-30 | 1984-01-06 | Glaxo Group Ltd | Nouvelles cephalosporines a activite antibiotique, leur procede de preparation et leur application en therapeutique |
FR2532936A1 (fr) * | 1982-09-13 | 1984-03-16 | Roussel Uclaf | Nouveaux derives de l'acide 2-amino-thiazolyl-4-yl acetique comportant une fonction oxime substituee et leur procede de preparation |
FR2536402A1 (fr) * | 1982-11-24 | 1984-05-25 | Glaxo Group Ltd | Cephalosporines, leur procede de preparation et leur application en therapeutique |
EP0111935A2 (fr) * | 1982-12-23 | 1984-06-27 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
EP0112164A2 (fr) * | 1982-12-13 | 1984-06-27 | Yamanouchi Pharmaceutical Co. Ltd. | Dérivés céphem, leur préparation et les médicaments les contenant |
EP0113243A2 (fr) * | 1982-12-24 | 1984-07-11 | Kureha Kagaku Kogyo Kabushiki Kaisha | Dérivés de céphalosporine |
EP0097961A3 (en) * | 1982-06-28 | 1984-10-03 | Bristol-Myers Company | Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives |
EP0132501A2 (fr) * | 1983-03-31 | 1985-02-13 | Ajinomoto Co., Inc. | Dérivés de céphalosporine, préparation et compositions pharmaceutiques |
FR2552089A2 (fr) * | 1981-05-13 | 1985-03-22 | Roussel Uclaf | Nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique, leur procede de preparation et leur application comme medicaments |
EP0135142A2 (fr) * | 1983-08-25 | 1985-03-27 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
EP0145906A2 (fr) * | 1983-10-31 | 1985-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de céphalosporine et procédés pour leur préparation |
EP0150609A2 (fr) * | 1983-12-30 | 1985-08-07 | Glaxo Group Limited | Antibiotiques de céphalosporine |
US4603129A (en) * | 1980-02-23 | 1986-07-29 | Hoechst Aktiengesellschaft | Cephalosporin derivatives |
EP0193858A1 (fr) * | 1985-03-01 | 1986-09-10 | Merck & Co. Inc. | Dérivés de 1-oxa-1-déthia-céphalosporine et agent antibactérien les contenant |
EP0214462A2 (fr) * | 1985-08-05 | 1987-03-18 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de 3-céphem 3,7-disubstitué et procédés pour leur préparation |
EP0221719A2 (fr) * | 1985-10-22 | 1987-05-13 | Biogal Gyogyszergyar | Dérivés de céphalosporine, leurs procédés de préparation et compositions pharmaceutiques les contenant |
EP0226093A2 (fr) * | 1985-12-03 | 1987-06-24 | Hoechst Aktiengesellschaft | Procédé pour la préparation de céfodizime |
EP0241901A2 (fr) * | 1986-04-14 | 1987-10-21 | Banyu Pharmaceutical Co., Ltd. | Dérivés de céphalosporine, leurs procédés de préparation et agents antibactériens |
US4708956A (en) * | 1985-12-12 | 1987-11-24 | Kyowa Hakko Kogyo Co., Ltd. | 3-position halogenated cephalosporin analogs and pharmaceutical compositions |
EP0272827A2 (fr) * | 1986-12-23 | 1988-06-29 | ZENECA Pharma S.A. | 3-Hétérocycliquethiométhyl céphalosporines |
EP0304155A2 (fr) * | 1987-07-23 | 1989-02-22 | ZENECA Pharma S.A. | Dérivés de céphalosporine, procédé pour leur préparation et leurs compositions pharmaceutiques |
EP0336705A2 (fr) * | 1988-04-05 | 1989-10-11 | Ajinomoto Co., Inc. | Composés céphem et procédé pour leur préparation |
EP0390066A2 (fr) * | 1989-03-29 | 1990-10-03 | Hoechst Aktiengesellschaft | Dérivés de céphalosporines et procédé pour leur préparation |
US5412093A (en) * | 1986-12-23 | 1995-05-02 | Ici Pharma | 3-heterocyclic thiomethyl cephalosporins |
Families Citing this family (186)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE878433A (fr) * | 1978-08-31 | 1980-02-25 | Fujisawa Pharmaceutical Co | Procede de preparation de derives d'acide 3-cephem-4-carboxylique 3,7-disubstitue, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne |
BE878514A (fr) * | 1978-09-04 | 1980-02-29 | Fujisawa Pharmaceutical Co | Procede de preparation de composes d'acide 3-cephem-4-carboxylique a disubstitution en positions 3 et 7, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne |
US4304770A (en) | 1976-04-12 | 1981-12-08 | Fujisawa Pharmaceutical Co., Ltd. | Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof |
US4493833A (en) * | 1976-04-12 | 1985-01-15 | Fujisawa Pharmaceutical Co., Ltd. | Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds |
US4409217A (en) * | 1977-03-14 | 1983-10-11 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
US4427674A (en) | 1977-03-14 | 1984-01-24 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
PH17188A (en) | 1977-03-14 | 1984-06-14 | Fujisawa Pharmaceutical Co | New cephem and cepham compounds and their pharmaceutical compositions and method of use |
DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
US5089490A (en) * | 1977-04-02 | 1992-02-18 | Hoechst Aktiengesellschaft | Cephem derivatives |
JPS5444695A (en) * | 1977-09-13 | 1979-04-09 | Fujisawa Pharmaceut Co Ltd | 3,7-disubstituted-3-cephem-4-carboxylic acid and its salt and their preparation |
FR2410655A1 (fr) * | 1977-12-05 | 1979-06-29 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
FR2387235A1 (fr) * | 1978-01-23 | 1978-11-10 | Fujisawa Pharmaceutical Co | Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne |
SE7902598L (sv) * | 1978-03-25 | 1979-10-04 | Kyowa Hakko Kogyo Kk | Cephalosporinanaloger |
JPS5936914B2 (ja) * | 1978-06-24 | 1984-09-06 | 協和醗酵工業株式会社 | セフアロスポリン類縁体 |
NO790956L (no) * | 1978-03-25 | 1979-09-26 | Kyowa Hakko Kogyo Kk | Analogifremgangsmaate til fremstilling av cefalosporinanaloge eller farmasoeytisk akseptable salter derav |
FR2432521A1 (fr) * | 1978-03-31 | 1980-02-29 | Roussel Uclaf | Nouvelles oximes o-substituees derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
SE448379B (sv) * | 1978-03-31 | 1987-02-16 | Roussel Uclaf | O-substituerade oximderivat av 7-amino-tiazolyl-acetamidocefalosporansyra |
US4374834A (en) * | 1978-04-07 | 1983-02-22 | Roussel Uclaf | Novel compounds |
FR2421907A1 (fr) * | 1978-04-07 | 1979-11-02 | Roussel Uclaf | Nouvelles cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl)2-(carboxymethoxyimino/acetamido 3-substitue cephalosporanique, leur procede de preparation et leur application comme medicaments |
AR229883A1 (es) * | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
AR231986A1 (es) * | 1978-05-26 | 1985-04-30 | Glaxo Group Ltd | Procedimiento para preparar antibioticos de cefalosporina |
EP0009548B1 (fr) * | 1978-07-17 | 1985-01-16 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de céphalosporine, procédé pour leur préparation, compositions pharmaceutiques les contenant |
US4284631A (en) * | 1978-07-31 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them |
US4372952A (en) | 1978-07-31 | 1983-02-08 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
BE878637A (fr) * | 1978-09-11 | 1980-03-06 | Fujisawa Pharmaceutical Co | Procede de preparation de composes d'acide 3-cephem-4-carboxylique 3,7-disubstitue et de leurs sels pharmaceutiquement acceptables, nouveaux produits ainsi obtenus et leur utilisation pour leurs activites antimicrobiennes |
US4341775A (en) * | 1978-09-11 | 1982-07-27 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
DE2945248A1 (de) * | 1978-11-13 | 1980-05-22 | Fujisawa Pharmaceutical Co | Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel |
JPS5585594A (en) * | 1978-11-13 | 1980-06-27 | Fujisawa Pharmaceut Co Ltd | Cephem compound and their preparation |
ES486026A1 (es) * | 1978-11-17 | 1980-09-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de antibioticos de ce- falosporina |
JPS5579393A (en) * | 1978-12-11 | 1980-06-14 | Takeda Chem Ind Ltd | Cephalosporin derivative and its preparation |
JPS6058920B2 (ja) * | 1978-12-26 | 1985-12-23 | 協和醗酵工業株式会社 | セフアロスポリン類縁体 |
FR2448543A1 (fr) | 1979-02-09 | 1980-09-05 | Roussel Uclaf | Nouvelles oximes o-substituees par un radical comportant un ammonium quaternaire et derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
JPS5671092A (en) * | 1979-11-14 | 1981-06-13 | Kyowa Hakko Kogyo Co Ltd | Optical active cephalosporin analogous derivative |
JPS5616491A (en) * | 1979-07-19 | 1981-02-17 | Kyowa Hakko Kogyo Co Ltd | Cephalosporin analog |
JPS55108877A (en) * | 1979-02-10 | 1980-08-21 | Kyowa Hakko Kogyo Co Ltd | Optically active cephalosporin analog |
NO155547C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling. |
NO155548C (no) * | 1979-02-10 | 1987-04-15 | Kyowa Hakko Kogyo Kk | Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger. |
IE49569B1 (en) * | 1979-03-22 | 1985-10-30 | Glaxo Group Ltd | Cephalosporin antibiotics |
US4339449A (en) | 1979-03-27 | 1982-07-13 | Fujisawa Pharmaceutical Company, Limited | Analogous compounds of cephalosporins, and pharmaceutical composition comprising the same |
US4331666A (en) * | 1979-05-11 | 1982-05-25 | Farmitalia Carlo Erba S.P.A. | 3-[(8-Carboxy-6-tetrazolo[1,5-b]pyridazinyl)-thiomethyl]-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino-acetamido]-3-cephem-4-carboxylic acid |
FR2461713A1 (fr) | 1979-07-19 | 1981-02-06 | Roussel Uclaf | Nouvelles alcoyloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl) acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
DE3069560D1 (en) | 1979-09-03 | 1984-12-06 | Fujisawa Pharmaceutical Co | Cephem compounds, processes for their preparation and pharmaceutical compositions containing them |
US4271157A (en) | 1980-02-28 | 1981-06-02 | E. R. Squibb & Sons, Inc. | Imidazole derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins |
US4409215A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical Co., Ltd. | 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof |
ZA806977B (en) * | 1979-11-19 | 1981-10-28 | Fujisawa Pharmaceutical Co | 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
US4409214A (en) * | 1979-11-19 | 1983-10-11 | Fujisawa Pharmaceutical, Co., Ltd. | 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof |
US4443443A (en) * | 1979-12-17 | 1984-04-17 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
US4405617A (en) * | 1980-02-11 | 1983-09-20 | Fujisawa Pharmaceutical Co., Ltd. | 3-(Propynyltetrazol)thiomethyl-3-cephems |
FR2476087A1 (fr) * | 1980-02-18 | 1981-08-21 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
JPS56131591A (en) * | 1980-02-20 | 1981-10-15 | Fujisawa Pharmaceut Co Ltd | 3,7-disubstituted-3-cephem-4-carboxylic acid compound, its salt, preparation thereof and preventing agent and remedy for microbism containing the same as active consitutent |
JPS56118085A (en) * | 1980-02-25 | 1981-09-16 | Takeda Chem Ind Ltd | 2-methylcephalosporin derivative and its preparation |
US4252802A (en) | 1980-03-13 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Hydroxamic acid derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins |
FR2479229B1 (fr) * | 1980-03-26 | 1986-01-17 | Clin Midy | Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives |
US4482551A (en) * | 1980-06-26 | 1984-11-13 | Hoffmann-La Roche Inc. | Cephalosporin derivatives |
US4308267A (en) | 1980-07-03 | 1981-12-29 | Smithkline Corporation | 7-[2-Alkoxyimino-2-(amino-thiazole)acetamido]-3-[1-(sulfaminoalkly)tetrazolthiomethyl]cephalosporins |
US4416879A (en) * | 1980-09-08 | 1983-11-22 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
NZ198350A (en) * | 1980-09-25 | 1985-02-28 | Toyama Chemical Co Ltd | Cephalosporins and intermediates;pharmaceutical compositions |
US4507293A (en) * | 1980-09-26 | 1985-03-26 | Fujisawa Pharmaceutical Co., Ltd. | Antimicrobial cephem compounds |
US4486425A (en) | 1980-09-30 | 1984-12-04 | Sankyo Company Limited | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates |
US4367228A (en) | 1980-10-29 | 1983-01-04 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compound and composition |
FR2494275A2 (fr) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | Nouveaux derives de vinyl-3 cephalosporines et leur preparation |
FR2494280A1 (fr) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | Nouveaux derives de la cephalosporine et leur preparation |
FR2494276A2 (fr) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | Nouvelles vinyl-3 cephalosporines, et leur preparation |
ES8303422A1 (es) * | 1980-12-15 | 1983-02-01 | Fujisawa Pharmaceutical Co | Un procedimiento para preparar derivados del acido 7-acilaminocefalosporanico . |
JPS6052754B2 (ja) * | 1981-01-29 | 1985-11-21 | 山之内製薬株式会社 | 7−アミノ−3−ハロゲノメチル−△↑3−セフェム−4−カルボン酸類およびその製法 |
EP0058250A3 (fr) * | 1981-02-17 | 1983-08-17 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Dérivés de céphalosporine, leur préparation et compositions pharmaceutiques les contenant |
JPS57156495A (en) * | 1981-03-23 | 1982-09-27 | Kyoto Yakuhin Kogyo Kk | Cephalosporin derivative and remedy for microbism used in oral administration |
JPS6011917B2 (ja) * | 1981-04-09 | 1985-03-28 | 山之内製薬株式会社 | 新規なセファロスポリン化合物 |
JPS57193489A (en) * | 1981-05-21 | 1982-11-27 | Fujisawa Pharmaceut Co Ltd | Syn-isomer of 7-substituted-3-cephem-4-carboxylic acid ester and its preparation |
US4577014A (en) * | 1981-09-08 | 1986-03-18 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
US4406898A (en) * | 1981-09-08 | 1983-09-27 | Eli Lilly And Company | Oxazole and oxadiazole cephalosporins |
US4382932A (en) * | 1981-09-08 | 1983-05-10 | Eli Lilly And Company | Isoquinolinium substituted cephalosporins |
US4474954A (en) * | 1981-12-07 | 1984-10-02 | Bristol-Myers Company | Intermediates for cephalosporin derivatives |
US4394503A (en) * | 1981-12-07 | 1983-07-19 | Bristol-Myers Company | Cephalosporin derivatives |
US4501739A (en) * | 1982-01-19 | 1985-02-26 | Eli Lilly And Company | Thieno and furopyridinium-substituted cephalosporins |
US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
JPS58167594A (ja) * | 1982-03-26 | 1983-10-03 | Sankyo Co Ltd | 経口用セフアロスポリン化合物 |
US4457929A (en) * | 1982-03-29 | 1984-07-03 | Bristol-Myers Company | 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives |
US4500526A (en) * | 1982-06-28 | 1985-02-19 | Bristol-Myers Company | Cephalosporin derivatives |
US4616081A (en) * | 1982-07-07 | 1986-10-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Cephalosporin compounds |
JPS59193889A (ja) * | 1983-04-18 | 1984-11-02 | Asahi Chem Ind Co Ltd | セフアロスポリン系化合物 |
JPS5910591A (ja) * | 1982-07-09 | 1984-01-20 | Meiji Seika Kaisha Ltd | 1−オキサデチアセフアロスポリン化合物及びそれを含む抗菌剤 |
JPS5951291A (ja) * | 1982-09-16 | 1984-03-24 | Meiji Seika Kaisha Ltd | オキサデチアセフアロスポリン中間体およびその製造法 |
JPS5946287A (ja) * | 1982-07-23 | 1984-03-15 | Meiji Seika Kaisha Ltd | 新規1−オキサ−1−デチア−セフアロスポリン誘導体 |
IL69246A (en) * | 1982-08-07 | 1986-07-31 | Tanabe Seiyaku Co | 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them |
US4473577A (en) * | 1982-10-22 | 1984-09-25 | Mitsui Toatsu Chemicals, Incorporated | 2-Thiazolamine derivatives, process for preparing same, and pharmaceutical compositions comprising same |
DK521883A (da) * | 1982-11-17 | 1984-05-18 | Toyama Chemical Co Ltd | Cephalosporinderivater, fremgangsmaade til fremstilling heraf og fremgangsmaade til fremstilling af mellemprodukter herfor |
JPS59104389A (ja) * | 1982-12-06 | 1984-06-16 | Shionogi & Co Ltd | オキサセファム誘導体 |
JPS59116291A (ja) * | 1982-12-06 | 1984-07-05 | Fujisawa Pharmaceut Co Ltd | 7−置換−3−セフエム−4−カルボン酸エステルおよびその製法 |
JPS59161386A (ja) * | 1983-03-01 | 1984-09-12 | Kureha Chem Ind Co Ltd | セフアロスポリン誘導体及び該誘導体を含有する医薬 |
JPS59118793A (ja) * | 1982-12-24 | 1984-07-09 | Kureha Chem Ind Co Ltd | セフアロスポリン誘導体及び該誘導体を含有する医薬 |
US4499088A (en) * | 1983-01-04 | 1985-02-12 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
JPS59155391A (ja) * | 1983-02-22 | 1984-09-04 | Tanabe Seiyaku Co Ltd | 新規セファロスポリン誘導体 |
US4525473A (en) * | 1983-03-30 | 1985-06-25 | Bristol-Myers Company | Cephalosporins |
US4514564A (en) * | 1983-04-18 | 1985-04-30 | Eli Lilly And Company | 7β-(2'-(1",3",5"-Triazepin-4"-one)-2'-(oxime ether)-acetamido)-3-substituted cephalosporins |
JPS59225193A (ja) * | 1983-06-02 | 1984-12-18 | Takeda Chem Ind Ltd | セフアロスポリンエステル |
JPS6041683A (ja) * | 1983-07-06 | 1985-03-05 | Asahi Chem Ind Co Ltd | 経口用セフアロスボリン誘導体 |
US4690921A (en) * | 1983-10-11 | 1987-09-01 | Yamanouchi Pharmaceutical Co., Ltd. | Cephalosporin compounds and salts thereof |
US4692443A (en) * | 1983-10-17 | 1987-09-08 | Eli Lilly And Company | 3-bicyclicpyridinium-methyl cephalosporins |
DE3485860T2 (de) * | 1983-12-29 | 1993-01-14 | Mochida Pharm Co Ltd | Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate. |
JPS60142987A (ja) * | 1983-12-29 | 1985-07-29 | Mochida Pharmaceut Co Ltd | セフアロスポリン誘導体 |
DE3404906A1 (de) * | 1984-02-11 | 1985-08-14 | Bayer Ag, 5090 Leverkusen | 1-oxadethiacephalosporinderivate sowie verfahren zu ihrer herstellung |
DE3405728A1 (de) * | 1984-02-17 | 1985-08-22 | Hoechst Ag, 6230 Frankfurt | Verwendung von cephemverbindungen als immunmodulatoren |
JPS60174787A (ja) * | 1984-02-21 | 1985-09-09 | Kyowa Hakko Kogyo Co Ltd | 3位置換カルバセフエム化合物 |
JPS60178891A (ja) * | 1984-02-24 | 1985-09-12 | Kureha Chem Ind Co Ltd | セファロスポリン誘導体及び該誘導体を含有する医薬 |
US4788185A (en) * | 1984-04-23 | 1988-11-29 | Takeda Chemical Industries, Ltd. | Cephalosporin compounds |
JPS60231682A (ja) * | 1984-05-02 | 1985-11-18 | Meiji Seika Kaisha Ltd | 新規セフアロスポリン系抗菌性化合物及びその製造法 |
DE3418376A1 (de) * | 1984-05-17 | 1985-11-21 | Bayer Ag, 5090 Leverkusen | Zwischenprodukte sowie verfahren zur herstellung von zwischenprodukten fuer die synthese von cephalosporinen |
FI851934L (fi) * | 1984-05-30 | 1985-12-01 | Ici Plc | Kefalosporinderivat. |
PH22107A (en) * | 1984-06-07 | 1988-06-01 | Takeda Chemical Industries Ltd | 3-pyrazolo(1,5-a)pyrdinium cephem compounds |
JPS6140291A (ja) * | 1984-07-31 | 1986-02-26 | Shionogi & Co Ltd | ヒドロキシアルキルチオセフアロスポリン |
JPS61178991A (ja) * | 1984-09-07 | 1986-08-11 | Meiji Seika Kaisha Ltd | 新規セフアロスポリン化合物 |
DK500285A (da) * | 1984-11-02 | 1986-05-03 | Glaxo Group Ltd | Cephalosporinantibiotika |
JPH0653739B2 (ja) * | 1984-11-15 | 1994-07-20 | 協和醗酵工業株式会社 | 3位置換カルバセフエム化合物 |
EP0182633A3 (fr) * | 1984-11-20 | 1987-09-02 | Ici Pharma | Dérivés de céphalosporine |
EP0187456A1 (fr) * | 1984-11-29 | 1986-07-16 | Ici Pharma | Dérivés de céphalosporine |
JPS61267584A (ja) * | 1985-01-16 | 1986-11-27 | Fujisawa Pharmaceut Co Ltd | セフアロスポラン酸誘導体もしくはその薬理学的に許容しうる塩 |
JPS61267585A (ja) * | 1985-01-16 | 1986-11-27 | Fujisawa Pharmaceut Co Ltd | セフアロスポラン酸誘導体もしくはその薬理学的に許容しうる塩 |
ATE89826T1 (de) * | 1985-03-01 | 1993-06-15 | Takeda Chemical Industries Ltd | Antibakterielle verbindungen, ihre herstellung und verwendung. |
US4840945A (en) * | 1985-04-01 | 1989-06-20 | Mochida Pharmaceutical Co., Ltd. | Cephalosporin derivatives |
HUT40660A (en) | 1985-04-30 | 1987-01-28 | Lilly Co Eli | Process for production of derivatives of 7-substituated bicyclic pirasilididone |
GB8519606D0 (en) * | 1985-08-05 | 1985-09-11 | Fujisawa Pharmaceutical Co | 3 7-d substituted-3-cephem compounds |
AR243179A1 (es) * | 1985-10-29 | 1993-07-30 | Merrell Dow Pharma | Procedimiento para preparar nuevas 5-(het)-2,4-dialquil-3h-1,2,4-triazolo-3-tionas |
US4670450A (en) * | 1985-11-13 | 1987-06-02 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic thiazolones |
IE862850L (en) * | 1985-11-21 | 1987-05-21 | Inst Animal Health Ltd | Intermediates for the preparation of beta-lactam antibiotics |
GB8626245D0 (en) * | 1985-11-27 | 1986-12-03 | Ici Pharma | Cephalosporin compounds |
EP0238060B1 (fr) | 1986-03-19 | 1992-01-08 | Banyu Pharmaceutical Co., Ltd. | Dérivés de céphalosporine, procédés pour leur préparation et agents antibactériens |
JP2503500B2 (ja) * | 1986-04-14 | 1996-06-05 | 萬有製薬株式会社 | 新規セフアロスポリン誘導体及びその製造法 |
US5596102A (en) * | 1986-05-23 | 1997-01-21 | Zeneca Limited | Biocides |
CA1283404C (fr) * | 1986-07-01 | 1991-04-23 | Shigeru Sanai | Composes de cephalosporine, procede de preparation et agents antibacteriens |
FR2621589B1 (fr) * | 1987-10-08 | 1990-03-02 | Sanofi Sa | Derives des cephalosporines a pharmacocinetique amelioree, procede pour leur preparation et compositions pharmaceutiques les contenant |
JPS63132893A (ja) * | 1986-11-25 | 1988-06-04 | Mochida Pharmaceut Co Ltd | 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤 |
US4880798A (en) * | 1986-11-25 | 1989-11-14 | Mochida Pharmaceutical Co., Ltd. | Cephalosporin derivatives |
JPS63284164A (ja) * | 1987-05-15 | 1988-11-21 | Ube Ind Ltd | 2−メチル−4−アミノ−5−アミノメチルピリミジン炭酸塩及びその製造方法 |
DE3854804T2 (de) * | 1987-07-23 | 1996-06-13 | Zeneca Pharma Sa | Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate |
US5223496A (en) * | 1987-11-10 | 1993-06-29 | The Upjohn Company | Cephalosporin antibiotics |
US4937332A (en) * | 1987-12-25 | 1990-06-26 | Taisho Pharmaceutical Co., Ltd. | Cephalosporin derivatives |
DE3804841A1 (de) * | 1988-02-17 | 1989-08-31 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
JPH01265093A (ja) * | 1988-10-12 | 1989-10-23 | Sankyo Co Ltd | 経口用セフアロスポリン化合物 |
US5391759A (en) * | 1988-12-19 | 1995-02-21 | Dowelanco | Preparation of 5-acylamino-1,2,4-triazole-3-sulfonamides |
DE3911322A1 (de) * | 1989-04-07 | 1990-10-11 | Hoechst Ag | Verfahren zur herstellung von cefodizim-dinatrium |
DE3919259A1 (de) * | 1989-06-13 | 1990-12-20 | Hoechst Ag | Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung |
KR930001114B1 (ko) * | 1990-07-20 | 1993-02-18 | 한국과학기술연구원 | 세팔로스포린 유도체 및 그의 제조방법 |
YU48484B (sh) * | 1991-05-24 | 1998-09-18 | Hoechst Aktiengesellschaft | Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline |
ATE262533T1 (de) * | 1991-09-07 | 2004-04-15 | Aventis Pharma Gmbh | Diastereomer des 3-cephem-4-carbonsäure-1-(- isopropoxycarbonyloxy)ethylesters und verfahren zu dessen herstellung |
AT398764B (de) * | 1992-01-28 | 1995-01-25 | Lek Tovarna Farmacevtskih | Verfahren zur herstellung von ceftriaxondinatrium-salzhemiheptahydrat |
TW212181B (fr) * | 1992-02-14 | 1993-09-01 | Hoechst Ag | |
AT399877B (de) * | 1992-02-20 | 1995-08-25 | Biochemie Gmbh | Neues verfahren zur herstellung von ceftriaxon |
ATE164378T1 (de) * | 1992-05-21 | 1998-04-15 | Hoechst Ag | Verfahren zur spaltung von cephalosporin prodrugestern zu 7-amino-3-methoxymethylceph-3-em-4-carbonsäure |
KR0154901B1 (ko) * | 1992-12-26 | 1998-11-16 | 성재갑 | 신규 세팔로스포린계 항생제(v) |
GB9423459D0 (en) * | 1994-11-21 | 1995-01-11 | Biochemie Gmbh | Silylation process |
AT402928B (de) * | 1994-12-23 | 1997-09-25 | Biochemie Gmbh | Neues verfahren zur herstellung von cefotaxim |
US7427680B2 (en) * | 2001-01-12 | 2008-09-23 | The Regents Of The University Of California | Fluorogenic substrates for BETA-lactamase gene expression |
US6121489A (en) * | 1996-03-05 | 2000-09-19 | Trega Biosciences, Inc. | Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein |
EP1214292B1 (fr) | 1999-09-24 | 2007-06-13 | Genentech, Inc. | Derives de tyrosine |
EP1392317A4 (fr) * | 2001-05-16 | 2005-10-19 | Antexpharma Inc | 1-benzazepines substituees et leurs derives |
EP1740173A4 (fr) * | 2004-03-23 | 2009-05-27 | Genentech Inc | Inhibiteurs azabicyclo-octane de l'iap |
JP4691549B2 (ja) | 2004-04-07 | 2011-06-01 | ノバルティス アーゲー | Iapの阻害剤 |
CN101005854A (zh) * | 2004-04-16 | 2007-07-25 | 健泰科生物技术公司 | 用于增进b细胞消除的方法 |
KR100984459B1 (ko) * | 2004-07-02 | 2010-09-29 | 제넨테크, 인크. | Iap의 억제제 |
CA2574040C (fr) | 2004-07-15 | 2014-05-06 | Tetralogic Pharmaceuticals Corporation | Composes de liaison aux proteines iap |
ATE477254T1 (de) | 2004-12-20 | 2010-08-15 | Genentech Inc | Pyrrolidine als inhibitoren von iap |
CA2598995C (fr) * | 2005-02-25 | 2014-07-15 | Stephen M. Condon | Inhibiteurs iap dimeriques |
US20100256046A1 (en) * | 2009-04-03 | 2010-10-07 | Tetralogic Pharmaceuticals Corporation | Treatment of proliferative disorders |
CA2632807A1 (fr) * | 2005-12-19 | 2007-09-20 | Genentech, Inc. | Inhibiteurs iap (inhibiteurs de l'apoptose) |
WO2008014236A1 (fr) * | 2006-07-24 | 2008-01-31 | Tetralogic Pharmaceuticals Corporation | Inhibiteurs d'iap dimériques |
WO2008014238A2 (fr) * | 2006-07-24 | 2008-01-31 | Tetralogic Pharmaceuticals Corporation | Inhibiteurs des iap dimères |
EP2049524A2 (fr) * | 2006-07-24 | 2009-04-22 | Tetralogic Pharmaceuticals Corporation | Inhibiteurs des iap |
US20100113326A1 (en) * | 2006-07-24 | 2010-05-06 | Tetralogic Pharmaceuticals Corporation | Dimeric iap inhibitors |
US7985735B2 (en) * | 2006-07-24 | 2011-07-26 | Tetralogic Pharmaceuticals Corporation | Dimeric IAP inhibitors |
PE20110224A1 (es) | 2006-08-02 | 2011-04-05 | Novartis Ag | PROCEDIMIENTO PARA LA SINTESIS DE UN PEPTIDOMIMETICO DE Smac INHIBIDOR DE IAP, Y COMPUESTOS INTERMEDIARIOS PARA LA SINTESIS DEL MISMO |
AU2007337104A1 (en) * | 2006-12-19 | 2008-07-03 | Genentech, Inc. | Imidazopyridine inhibitors of IAP |
MX2009011783A (es) * | 2007-04-30 | 2009-12-04 | Genentech Inc | Inhibidores de iap. |
WO2009089502A1 (fr) * | 2008-01-11 | 2009-07-16 | Genentech, Inc. | Inhibiteurs de iap |
JP2011529962A (ja) | 2008-08-02 | 2011-12-15 | ジェネンテック, インコーポレイテッド | Iapのインヒビター |
CA2730357A1 (fr) * | 2008-08-16 | 2010-02-25 | Genetech, Inc. | Inhibiteurs azaindoles d'iap |
US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
WO2011072064A1 (fr) | 2009-12-08 | 2011-06-16 | Array Biopharma Inc. | Spiro[chromane-4,4'-imidazol]ones en tant qu'inhibiteurs de bêta-sécrétase |
WO2011123674A1 (fr) | 2010-03-31 | 2011-10-06 | Array Biopharma Inc. | Composés pour traiter des maladies neurodégénératives |
WO2011130741A1 (fr) | 2010-04-16 | 2011-10-20 | Array Biopharma Inc. | Composés pour le traitement de maladies neurodégénératives |
AR083953A1 (es) | 2010-11-22 | 2013-04-10 | Array Biopharma Inc | Compuestos para tratar enfermedades neurodegenerativas |
MX2016008624A (es) | 2013-12-30 | 2017-01-06 | Genentech Inc | Inhibidores de serina/treonina cinasa. |
JP6769963B2 (ja) | 2014-08-29 | 2020-10-14 | ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ | α−アミノ−β−カルボキシムコン酸セミアルデヒド脱炭酸酵素の阻害剤 |
AU2017319500C1 (en) | 2016-08-31 | 2022-10-20 | Les Laboratoires Servier | Inhibitors of cellular metabolic processes |
WO2019060051A1 (fr) | 2017-08-04 | 2019-03-28 | Ardelyx, Inc. | Dérivés d'acide glycyrrhétinique de traitement de l'hyperkaliémie |
WO2020163642A1 (fr) | 2019-02-07 | 2020-08-13 | Ardelyx, Inc. | Dérivés d'acide glycyrrhétinique destinés à être utilisés dans le traitement de l'hyperkaliémie |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2123544A1 (fr) * | 1971-01-29 | 1972-09-08 | Glaxo Lab Ltd | |
FR2137899A1 (fr) * | 1971-05-14 | 1972-12-29 | Glaxo Lab Ltd | |
FR2294690A1 (fr) * | 1974-12-19 | 1976-07-16 | Takeda Chemical Industries Ltd | Composes thiazo-lylacetamido |
FR2346014A1 (fr) * | 1976-01-23 | 1977-10-28 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
FR2348218A1 (fr) * | 1976-04-14 | 1977-11-10 | Takeda Chemical Industries Ltd | Nouveaux derives cephalosporines ayant un nouveau groupe 7-acyle et leur procede de fabrication |
FR2361893A2 (fr) * | 1976-01-23 | 1978-03-17 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE36041B1 (en) * | 1971-01-29 | 1976-08-04 | Glaxo Lab Ltd | Improvements in or relating to antibiotics |
US4091211A (en) * | 1974-05-05 | 1978-05-23 | Hoffmann-La Roche Inc. | Cephalosporins |
US4020058A (en) * | 1974-10-03 | 1977-04-26 | Glaxo Laboratories Limited | Improvements in or relating to cephalosporin antibiotics |
US4166155A (en) * | 1974-10-11 | 1979-08-28 | Gould Inc. | Maintenance-free battery |
JPS5167524A (ja) * | 1974-12-09 | 1976-06-11 | Hitachi Ltd | Benchireeshonbarubu |
JPS5760345B2 (fr) * | 1974-12-19 | 1982-12-18 | Takeda Chemical Industries Ltd | |
US4298606A (en) * | 1974-12-19 | 1981-11-03 | Takeda Chemical Industries, Ltd. | Thiazolylacetamido compounds |
DE2760123C2 (de) * | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
SE440655B (sv) * | 1976-01-23 | 1985-08-12 | Roussel Uclaf | Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra |
GB1575803A (en) * | 1976-03-09 | 1980-10-01 | Fujisawa Pharmaceutical Co | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
FR2345153A1 (fr) * | 1976-03-25 | 1977-10-21 | Roussel Uclaf | Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
US4202893A (en) * | 1976-03-25 | 1980-05-13 | Roussel Uclaf | Alkyloximes of 7-amino-thiazolyl-acetamido-cephalosporanic acids |
US4166115A (en) * | 1976-04-12 | 1979-08-28 | Fujisawa Pharmaceutical Co., Ltd. | Syn 7-oxoimino substituted derivatives of cephalosporanic acid |
GB1576625A (en) * | 1976-04-12 | 1980-10-08 | Fujisawa Pharmaceutical Co | Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof |
DK162391C (da) * | 1976-04-12 | 1992-03-09 | Fujisawa Pharmaceutical Co | Analogifremgangsmaade til fremstilling af syn-isomerer af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser |
JPS597717B2 (ja) * | 1976-09-08 | 1984-02-20 | 武田薬品工業株式会社 | セフアロスポリン誘導体およびその製造法 |
FR2361895A1 (fr) * | 1976-08-20 | 1978-03-17 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
JPS6011713B2 (ja) * | 1976-09-08 | 1985-03-27 | 武田薬品工業株式会社 | セフアロスポリン誘導体およびその製造法 |
FR2381053A1 (fr) * | 1977-02-18 | 1978-09-15 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-thiadiazolyl thiomethyl 7-aminothiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
JPS53103493A (en) * | 1977-02-18 | 1978-09-08 | Takeda Chem Ind Ltd | Cephalosporin derivatives and process for their preparation |
PH17188A (en) * | 1977-03-14 | 1984-06-14 | Fujisawa Pharmaceutical Co | New cephem and cepham compounds and their pharmaceutical compositions and method of use |
FR2384782A1 (fr) * | 1977-03-25 | 1978-10-20 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
FR2384779A1 (fr) * | 1977-03-25 | 1978-10-20 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 3-chloro ou 3-methoxy 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
DE2714880A1 (de) * | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
AR229883A1 (es) * | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
US4341775A (en) * | 1978-09-11 | 1982-07-27 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
KR0157073B1 (ko) * | 1992-10-01 | 1998-11-16 | 김태훈 | 세팔로스포린 유도체 및 그의 제조방법 |
-
1977
- 1977-04-02 DE DE19772714880 patent/DE2714880A1/de not_active Withdrawn
- 1977-04-15 DE DE19772716707 patent/DE2716707A1/de active Granted
-
1978
- 1978-03-30 GB GB12461/78A patent/GB1604971A/en not_active Expired
- 1978-03-30 CH CH341178A patent/CH638810A5/de not_active IP Right Cessation
- 1978-03-30 FI FI780966A patent/FI70221C/fi not_active IP Right Cessation
- 1978-03-30 US US06/891,850 patent/US4758556A/en not_active Ceased
- 1978-03-31 IT IT21901/78A patent/IT1093750B/it active Protection Beyond IP Right Term
- 1978-03-31 SE SE7803660A patent/SE448378B/sv not_active IP Right Cessation
- 1978-03-31 DK DK143378A patent/DK165060C/da not_active IP Right Cessation
- 1978-03-31 CA CA000300245A patent/CA1259606A/fr not_active Expired
- 1978-03-31 NL NL7803486A patent/NL7803486A/xx not_active Application Discontinuation
- 1978-03-31 IE IE642/78A patent/IE47211B1/en active Protection Beyond IP Right Term
- 1978-03-31 AT AT0229078A patent/AT367425B/de not_active IP Right Cessation
- 1978-03-31 NO NO781130A patent/NO160211C/no unknown
- 1978-03-31 PT PT67856A patent/PT67856B/pt unknown
- 1978-03-31 DD DD78204534A patent/DD137231A5/xx unknown
- 1978-03-31 FR FR7809661A patent/FR2385722B1/fr not_active Expired
- 1978-03-31 LU LU79350A patent/LU79350A1/de unknown
- 1978-03-31 AU AU34648/78A patent/AU528277B2/en not_active Expired
- 1978-03-31 NZ NZ186842A patent/NZ186842A/xx unknown
- 1978-03-31 JP JP53038745A patent/JPS5858354B2/ja not_active Expired
- 1978-03-31 IL IL54407A patent/IL54407A/xx unknown
- 1978-03-31 YU YU765/78A patent/YU41827B/xx unknown
- 1978-04-01 OA OA56457A patent/OA05928A/fr unknown
- 1978-04-01 ES ES468475A patent/ES468475A1/es not_active Expired
- 1978-04-01 GR GR55860A patent/GR73632B/el unknown
- 1978-04-03 CS CS782144A patent/CS208747B2/cs unknown
- 1978-04-03 BE BE186522A patent/BE865632A/fr not_active IP Right Cessation
-
1979
- 1979-02-09 ES ES477591A patent/ES477591A1/es not_active Expired
-
1980
- 1980-07-21 US US06/170,839 patent/US4278793A/en not_active Expired - Lifetime
-
1981
- 1981-04-07 JP JP5233981A patent/JPS5716887A/ja active Granted
- 1981-05-22 FR FR8110233A patent/FR2485017A1/fr active Granted
- 1981-05-22 FR FR8110234A patent/FR2485018A1/fr active Granted
-
1983
- 1983-10-06 HK HK390/83A patent/HK39083A/xx not_active IP Right Cessation
- 1983-12-16 SE SE8306994A patent/SE8306994D0/xx not_active Application Discontinuation
-
1990
- 1990-07-11 US US07/551,615 patent/USRE35754E/en not_active Expired - Lifetime
-
1994
- 1994-07-22 US US08/279,097 patent/US5710146A/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2123544A1 (fr) * | 1971-01-29 | 1972-09-08 | Glaxo Lab Ltd | |
FR2137899A1 (fr) * | 1971-05-14 | 1972-12-29 | Glaxo Lab Ltd | |
FR2294690A1 (fr) * | 1974-12-19 | 1976-07-16 | Takeda Chemical Industries Ltd | Composes thiazo-lylacetamido |
FR2346014A1 (fr) * | 1976-01-23 | 1977-10-28 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
FR2361893A2 (fr) * | 1976-01-23 | 1978-03-17 | Roussel Uclaf | Nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments |
FR2348218A1 (fr) * | 1976-04-14 | 1977-11-10 | Takeda Chemical Industries Ltd | Nouveaux derives cephalosporines ayant un nouveau groupe 7-acyle et leur procede de fabrication |
Cited By (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2399418A1 (fr) * | 1977-03-14 | 1979-03-02 | Fujisawa Pharmaceutical Co | Procede de preparation d'acides iminoacetiques et nouveaux produits ainsi obtenus, utilises pour la synthese d'acides cepham- ou cephem-carboxyliques |
FR2453161A1 (fr) * | 1978-08-31 | 1980-10-31 | Fujisawa Pharmaceutical Co | Procede de preparation de derives d'acide thiazolylacetique et nouveaux produits ainsi obtenus |
EP0076528A2 (fr) * | 1980-02-18 | 1983-04-13 | Roussel-Uclaf | Nouvelles oximes dérivées de l'acide 3-alkyloxy ou 3-alkylthiométhyl 7-amino thiazolylacétamido céphalosporanique et leur préparation |
EP0104671A2 (fr) * | 1980-02-18 | 1984-04-04 | Roussel-Uclaf | Nouvelles oximes dérivées de l'acide 3-alkyloxy ou 3-alkylthiométhyl-7 amino thiazolylacétamido céphalosporaniques, leur préparation, leur application comme médicaments et les compositions les renfermant |
EP0104671B1 (fr) * | 1980-02-18 | 1990-05-23 | Roussel-Uclaf | Nouvelles oximes dérivées de l'acide 3-alkyloxy ou 3-alkylthiométhyl-7 amino thiazolylacétamido céphalosporaniques, leur préparation, leur application comme médicaments et les compositions les renfermant |
EP0076528B1 (fr) * | 1980-02-18 | 1990-05-23 | Roussel-Uclaf | Nouvelles oximes dérivées de l'acide 3-alkyloxy ou 3-alkylthiométhyl 7-amino thiazolylacétamido céphalosporanique et leur préparation |
US4603129A (en) * | 1980-02-23 | 1986-07-29 | Hoechst Aktiengesellschaft | Cephalosporin derivatives |
FR2476647A2 (fr) * | 1980-02-26 | 1981-08-28 | Roussel Uclaf | Procede de preparation de derives de l'acide 2-(2-amino protege 4-thiazolyl) 2-alkoxyimino acetique isomere syn |
EP0045937A3 (en) * | 1980-08-11 | 1982-10-13 | Fujisawa Pharmaceutical Co. Ltd. | New cephem compounds and processes for preparation thereof |
FR2488258A1 (fr) * | 1980-08-11 | 1982-02-12 | American Cyanamid Co | Acide 7-beta-(alpha-syn-methoxyimino-alpha - (2-aminothiazol-4-yl) - acetamino)-3-((1,2,3-thiadiazol-5-ylthio) methyl)-3-cepheme-4-carboxylique et derives alkyliques en c1-c6 de celui-ci, compositions contenant ces composes et leurs applications |
EP0045937A2 (fr) * | 1980-08-11 | 1982-02-17 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de céphalosporine et procédés pour leur préparation |
EP0134420A1 (fr) * | 1980-09-30 | 1985-03-20 | Sankyo Company Limited | Dérivés de céphalosporines, leur préparation et compositions pharmaceutiques |
EP0049119A2 (fr) * | 1980-09-30 | 1982-04-07 | Sankyo Company Limited | Dérivés de céphalosporines, leur préparation et compositions pharmaceutiques les contenant |
EP0049119A3 (en) * | 1980-09-30 | 1983-02-09 | Sankyo Company Limited | Cephalosporin derivatives, a process for their preparation and compositions containing them |
EP0049499A3 (en) * | 1980-10-06 | 1983-09-07 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and intermediates for their preparation |
EP0049499A2 (fr) * | 1980-10-06 | 1982-04-14 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Dérivés de céphalosporine, leur préparation, compositions pharmaceutiques les contenant et intermédiaires pour leur préparation |
FR2494279A1 (fr) * | 1980-11-20 | 1982-05-21 | Rhone Poulenc Ind | Nouvelles oxacephalosporines, leur preparation et les medicaments qui les contiennent |
EP0053072A1 (fr) * | 1980-11-20 | 1982-06-02 | Rhone-Poulenc Sante | Nouvelles oxacéphalosporines et leur préparation |
EP0053071A1 (fr) * | 1980-11-20 | 1982-06-02 | Rhone-Poulenc Sante | Nouvelles oxacéphalosporines, leur préparation et les médicaments qui les contiennent |
EP0053541A1 (fr) * | 1980-11-20 | 1982-06-09 | Rhone-Poulenc Sante | Nouvelles oxacéphalosporines et leur préparation |
EP0053073A1 (fr) * | 1980-11-20 | 1982-06-02 | Rhone-Poulenc Sante | Nouvelles oxacéphalosporines et leur préparation |
EP0075600A4 (fr) * | 1981-03-16 | 1983-05-16 | Mitsui Toatsu Chemicals | Derives de 2-thiazolamines, leur procede de preparation et composition medicinale les contenant. |
EP0075600A1 (fr) * | 1981-03-16 | 1983-04-06 | MITSUI TOATSU CHEMICALS, Inc. | Derives de 2-thiazolamines, leur procede de preparation et composition medicinale les contenant |
EP0064256A2 (fr) * | 1981-05-02 | 1982-11-10 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
EP0064256A3 (en) * | 1981-05-02 | 1983-11-23 | Hoechst Aktiengesellschaft | Cephalosporin derivatives and process for their preparation |
FR2505339A1 (fr) * | 1981-05-11 | 1982-11-12 | Rhone Poulenc Sante | Nouvelles oxacephalosporines et leur preparation |
FR2505338A1 (fr) * | 1981-05-11 | 1982-11-12 | Rhone Poulenc Sante | Nouvelles oxacephalosporines et leur preparation |
FR2515654A1 (fr) * | 1981-05-12 | 1983-05-06 | Hoechst Ag | Derives de cephalosporine utilisables comme produits intermediaires pour la preparation de produits a activite therapeutique |
FR2511682A1 (fr) * | 1981-05-12 | 1983-02-25 | Hoechst Ag | Derives de cephalosporine, leur procede de preparation et leur application therapeutique |
EP0064740A3 (en) * | 1981-05-12 | 1983-11-23 | Hoechst Aktiengesellschaft | Cephalosporin derivatives, and process for their preparation |
EP0064740A2 (fr) * | 1981-05-12 | 1982-11-17 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
FR2552089A2 (fr) * | 1981-05-13 | 1985-03-22 | Roussel Uclaf | Nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique, leur procede de preparation et leur application comme medicaments |
FR2505840A1 (fr) * | 1981-05-13 | 1982-11-19 | Roussel Uclaf | Nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique, leur procede de preparation et leur application comme medicaments |
US4476124A (en) * | 1981-05-13 | 1984-10-09 | Roussel Uclaf | 2-Amino-4-thiazolyl-2-oxyimino-acetamido-bicyclooctene-carboxylic acids |
FR2508458A1 (fr) * | 1981-06-29 | 1982-12-31 | Sandoz Sa | Nouveaux derives de l'acide cephalosporanique, leur preparation et leur application comme medicaments |
FR2511002A1 (fr) * | 1981-06-29 | 1983-02-11 | Sandoz Ag | |
EP0074268A2 (fr) * | 1981-09-08 | 1983-03-16 | Eli Lilly And Company | Dérivés de céphalosporines thiéno- et furopyridinium substitués |
FR2512448A1 (fr) * | 1981-09-08 | 1983-03-11 | Lilly Co Eli | Isoquinoleinium-betaines de cephalosporine et son application pharmaceutique |
FR2512449A1 (fr) * | 1981-09-08 | 1983-03-11 | Lilly Co Eli | Quinoleinium-betaines de cephalosporine et leur application pharmacolique |
EP0074268A3 (fr) * | 1981-09-08 | 1984-05-23 | Eli Lilly And Company | Dérivés de céphalosporines thiéno- et furopyridinium substitués |
EP0074645A3 (en) * | 1981-09-14 | 1984-06-13 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds, processes for their preparation and pharmaceutical antibacterial composition containing them |
EP0074645A2 (fr) * | 1981-09-14 | 1983-03-23 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de céphalosporine, procédés pour leur préparation et compositions pharmaceutiques les contenant |
FR2514004A1 (fr) * | 1981-10-02 | 1983-04-08 | Lilly Co Eli | Antibiotiques de dioximino-cephalosporines |
EP0078532A2 (fr) * | 1981-11-03 | 1983-05-11 | Hoechst Aktiengesellschaft | Sels cristallins de céfodizim et procédé pour leur préparation |
EP0078532A3 (en) * | 1981-11-03 | 1984-09-12 | Hoechst Aktiengesellschaft | Crystalline salts of cephodizime, and process for their preparation |
EP0081971A2 (fr) * | 1981-12-08 | 1983-06-22 | Tanabe Seiyaku Co., Ltd. | Dérivé de céphalosporine et procédé pour sa préparation |
US4576938A (en) * | 1981-12-08 | 1986-03-18 | Tanabe Seiyaku Co., Ltd. | Cephalosporin compound and process for preparing the same |
EP0081971A3 (fr) * | 1981-12-08 | 1984-09-26 | Tanabe Seiyaku Co., Ltd. | Dérivé de céphalosporine et procédé pour sa préparation |
EP0095329A3 (fr) * | 1982-05-20 | 1984-11-28 | Glaxo Group Limited | Céphalosporines antibiotiques |
EP0095329A2 (fr) * | 1982-05-20 | 1983-11-30 | Glaxo Group Limited | Céphalosporines antibiotiques |
EP0097961A3 (en) * | 1982-06-28 | 1984-10-03 | Bristol-Myers Company | Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives |
FR2543949A1 (fr) * | 1982-06-30 | 1984-10-12 | Glaxo Group Ltd | Derives de l'acide 2-cyclopropylmethoxyimino-2-(thiazole-4-yl) acetique, leur procede de preparation et leur application a la preparation d'antibiotiques de type cephalosporine |
FR2529556A1 (fr) * | 1982-06-30 | 1984-01-06 | Glaxo Group Ltd | Nouvelles cephalosporines a activite antibiotique, leur procede de preparation et leur application en therapeutique |
FR2529555A1 (fr) * | 1982-06-30 | 1984-01-06 | Glaxo Group Ltd | Cephalosporines a activite antibiotique, leur procede de preparation et leur application en therapeutique |
FR2532936A1 (fr) * | 1982-09-13 | 1984-03-16 | Roussel Uclaf | Nouveaux derives de l'acide 2-amino-thiazolyl-4-yl acetique comportant une fonction oxime substituee et leur procede de preparation |
FR2536402A1 (fr) * | 1982-11-24 | 1984-05-25 | Glaxo Group Ltd | Cephalosporines, leur procede de preparation et leur application en therapeutique |
EP0112164A2 (fr) * | 1982-12-13 | 1984-06-27 | Yamanouchi Pharmaceutical Co. Ltd. | Dérivés céphem, leur préparation et les médicaments les contenant |
EP0112164A3 (fr) * | 1982-12-13 | 1985-06-26 | Yamanouchi Pharmaceutical Co. Ltd. | Dérivés céphem, leur préparation et les médicaments les contenant |
EP0111935A3 (en) * | 1982-12-23 | 1985-07-03 | Hoechst Aktiengesellschaft | Cephalosporin derivatives and process for their preparation |
EP0111935A2 (fr) * | 1982-12-23 | 1984-06-27 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
EP0113243A2 (fr) * | 1982-12-24 | 1984-07-11 | Kureha Kagaku Kogyo Kabushiki Kaisha | Dérivés de céphalosporine |
EP0113243A3 (en) * | 1982-12-24 | 1985-05-02 | Kureha Kagaku Kogyo Kabushiki Kaisha | Cephalosporin derivatives |
EP0132501A3 (fr) * | 1983-03-31 | 1985-09-18 | Ajinomoto Co., Inc. | Dérivés de céphalosporine, préparation et compositions pharmaceutiques |
EP0132501A2 (fr) * | 1983-03-31 | 1985-02-13 | Ajinomoto Co., Inc. | Dérivés de céphalosporine, préparation et compositions pharmaceutiques |
EP0135142A3 (en) * | 1983-08-25 | 1986-01-08 | Hoechst Aktiengesellschaft | Cephalosporin derivatives and process for their preparation |
EP0135142A2 (fr) * | 1983-08-25 | 1985-03-27 | Hoechst Aktiengesellschaft | Dérivés de céphalosporine et procédé pour leur préparation |
EP0145906A2 (fr) * | 1983-10-31 | 1985-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de céphalosporine et procédés pour leur préparation |
EP0145906B1 (fr) * | 1983-10-31 | 1992-03-11 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de céphalosporine et procédés pour leur préparation |
EP0150609A3 (fr) * | 1983-12-30 | 1986-04-23 | Glaxo Group Limited | Antibiotiques de céphalosporine |
EP0150609A2 (fr) * | 1983-12-30 | 1985-08-07 | Glaxo Group Limited | Antibiotiques de céphalosporine |
EP0193858A1 (fr) * | 1985-03-01 | 1986-09-10 | Merck & Co. Inc. | Dérivés de 1-oxa-1-déthia-céphalosporine et agent antibactérien les contenant |
EP0214462A2 (fr) * | 1985-08-05 | 1987-03-18 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de 3-céphem 3,7-disubstitué et procédés pour leur préparation |
EP0214462A3 (fr) * | 1985-08-05 | 1987-12-09 | Fujisawa Pharmaceutical Co., Ltd. | Dérivés de 3-céphem 3,7-disubstitué et procédés pour leur préparation |
EP0221719A2 (fr) * | 1985-10-22 | 1987-05-13 | Biogal Gyogyszergyar | Dérivés de céphalosporine, leurs procédés de préparation et compositions pharmaceutiques les contenant |
EP0221719A3 (fr) * | 1985-10-22 | 1987-12-16 | Biogal Gyogyszergyar | Dérivés de céphalosporine, leurs procédés de préparation et compositions pharmaceutiques les contenant |
EP0226093A2 (fr) * | 1985-12-03 | 1987-06-24 | Hoechst Aktiengesellschaft | Procédé pour la préparation de céfodizime |
EP0226093A3 (en) * | 1985-12-03 | 1988-11-09 | Hoechst Aktiengesellschaft | Process for the preparation of cefodizime |
US4708956A (en) * | 1985-12-12 | 1987-11-24 | Kyowa Hakko Kogyo Co., Ltd. | 3-position halogenated cephalosporin analogs and pharmaceutical compositions |
EP0241901A2 (fr) * | 1986-04-14 | 1987-10-21 | Banyu Pharmaceutical Co., Ltd. | Dérivés de céphalosporine, leurs procédés de préparation et agents antibactériens |
EP0241901A3 (en) * | 1986-04-14 | 1989-06-14 | Banyu Pharmaceutical Co., Ltd. | Cephalosporin derivatives, processes for their preparation and antibacterial agents |
EP0272827A3 (fr) * | 1986-12-23 | 1990-02-07 | ZENECA Pharma S.A. | 3-Hétérocycliquethiométhyl céphalosporines |
EP0272827A2 (fr) * | 1986-12-23 | 1988-06-29 | ZENECA Pharma S.A. | 3-Hétérocycliquethiométhyl céphalosporines |
US5412093A (en) * | 1986-12-23 | 1995-05-02 | Ici Pharma | 3-heterocyclic thiomethyl cephalosporins |
US5057511A (en) * | 1986-12-23 | 1991-10-15 | Ici Pharma | 3-heterocyclic thiomethyl cephalosporins |
EP0304155A2 (fr) * | 1987-07-23 | 1989-02-22 | ZENECA Pharma S.A. | Dérivés de céphalosporine, procédé pour leur préparation et leurs compositions pharmaceutiques |
EP0304155B1 (fr) * | 1987-07-23 | 1995-11-15 | ZENECA Pharma S.A. | Dérivés de céphalosporine, procédé pour leur préparation et leurs compositions pharmaceutiques |
EP0336705A2 (fr) * | 1988-04-05 | 1989-10-11 | Ajinomoto Co., Inc. | Composés céphem et procédé pour leur préparation |
EP0336705A3 (fr) * | 1988-04-05 | 1991-07-03 | Ajinomoto Co., Inc. | Composés céphem et procédé pour leur préparation |
EP0390066A3 (fr) * | 1989-03-29 | 1992-02-26 | Hoechst Aktiengesellschaft | Dérivés de céphalosporines et procédé pour leur préparation |
US5306717A (en) * | 1989-03-29 | 1994-04-26 | Hoechst Aktiengesellschaft | Cephalosporin derivatives |
EP0390066A2 (fr) * | 1989-03-29 | 1990-10-03 | Hoechst Aktiengesellschaft | Dérivés de céphalosporines et procédé pour leur préparation |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2385722A1 (fr) | Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique | |
FR2387234A1 (fr) | Derives de cephalosporine, leur procede de preparation et leurs applications en therapeutique | |
FR2392016A1 (fr) | Derives de mevalonolactone, leur procede de preparation et leur application therapeutique | |
FR2364219A1 (fr) | Derives de thiazolidine, leur procede de preparation et leur application en therapeutique | |
FR2384765A1 (fr) | Derives amino-substitues du furanne et procede pour leur preparation | |
FR2378521A1 (fr) | Derives du carbostyrile, utiles notamment comme stimulants des centres b- adrenorecepteurs, et leur procede de preparation | |
FR2375250A1 (fr) | 3-de-0-methylfortimicines, leur procede de preparation et leur utilisation therapeutique comme antibiotiques | |
FR2366297A1 (fr) | Nouvelles cephalosporines, leur procede de preparation et leur application en therapeutique | |
FR2405246A1 (fr) | Nouveaux derives de pyrrole, leur procede de preparation et leurs applications en therapeutique | |
FR2400500A1 (fr) | Derives d'acides cycloalcoylidenemethylphenylacetiques, leur procede de preparation et leur application en therapeutique | |
FR2446283A1 (fr) | Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques | |
FR2427337A1 (fr) | Nouveaux derives acyles de la cephalosporine, leur preparation et leurs utilisations therapeutiques | |
FR2381753A1 (fr) | Nouveaux derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique | |
FR2387988A1 (fr) | Esters de cefuroxime, leur preparation et leur application therapeutique | |
FR2384811A1 (fr) | Derives de la neocarzinostatine, leur application therapeutique et leur procede de preparation | |
FR2453151A1 (fr) | Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique | |
FR2421900A1 (fr) | Piperazino-3-indoles, leur procede de preparation et leurs applications therapeutiques | |
FR2355849A1 (fr) | Derives de l'acide 7 b-acylamidoceph-3-eme 4-carboxyliques, leur procede de preparation et application therapeutique | |
FR2355020A1 (fr) | Antibiotiques de b-lactames et leur procede de preparation | |
FR2388789A1 (fr) | Derives d'acide benzoique, leur procede de preparation et leur application therapeutique | |
FR2355831A1 (fr) | Derives de benzazocine, leur procede de preparation et leur application therapeutique | |
FR2358401A1 (fr) | Nouveaux derives d'oxadiazine, leur procede de preparation et leur application comme insecticides | |
FR2361881A2 (fr) | Nouveaux sulfoxydes, leur procede de preparation et leur application | |
FR2368489A1 (fr) | Derives de la clavuline, leur procede de preparation et leur application en therapeutique | |
FR2446282A1 (fr) | Phenylthiophenylpiperidines, leur preparation et leurs applications therapeutiques |